Enzo Biochem, Inc.Enzo Biochem, Inc.Enzo Biochem, Inc.

Enzo Biochem, Inc.

No trades
See on Supercharts
Market capitalization
‪57.89 M‬USD
‪−62.34 M‬USD
‪31.06 M‬USD
‪35.62 M‬
Beta (1Y)
−0.26

About Enzo Biochem, Inc.

CEO
Kara Cannon
Website
Headquarters
New York
Employees (FY)
190
Founded
1976
ISIN
US2941001024
FIGI
BBG000BHY9Q4
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ENZ is 1.09 USD — it has decreased by 3.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Enzo Biochem, Inc. stocks are traded under the ticker ENZ.
Enzo Biochem, Inc. is going to release the next earnings report on Jun 10, 2024. Keep track of upcoming events with our Earnings Calendar.
ENZ stock is 5.61% volatile and has beta coefficient of −0.26. Check out the list of the most volatile stocks — is Enzo Biochem, Inc. there?
ENZ earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.15 USD resulting in a 6.67% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about Enzo Biochem, Inc. earnings.
Enzo Biochem, Inc. revenue for the last quarter amounts to ‪19.66 M‬ USD despite the estimated figure of ‪19.31 M‬ USD. In the next quarter revenue is expected to reach ‪19.66 M‬ USD.
Yes, you can track Enzo Biochem, Inc. financials in yearly and quarterly reports right on TradingView.
ENZ stock has fallen by 9.92% compared to the previous week, the month change is a 12.80% fall, over the last year Enzo Biochem, Inc. has showed a 54.58% decrease.
ENZ net income for the last quarter is ‪−3.06 M‬ USD, while the quarter before that showed ‪−6.62 M‬ USD of net income which accounts for 53.73% change. Track more Enzo Biochem, Inc. financial stats to get the full picture.
Today Enzo Biochem, Inc. has the market capitalization of ‪57.89 M‬, it has decreased by 6.25% over the last week.
No, ENZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enzo Biochem, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ENZ reached its all-time high on Jan 24, 2000 with the price of 114.36 USD, and its all-time low was 0.40 USD and was reached on Jun 28, 1991.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 190.00 employees. See our rating of the largest employees — is Enzo Biochem, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enzo Biochem, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enzo Biochem, Inc. stock shows the sell signal. See more of Enzo Biochem, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.